A detailed history of Harmony Asset Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Harmony Asset Management LLC holds 4,458 shares of GILD stock, worth $412,677. This represents 0.14% of its overall portfolio holdings.

Number of Shares
4,458
Previous 3,824 16.58%
Holding current value
$412,677
Previous $262 Million 42.48%
% of portfolio
0.14%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$66.59 - $83.99 $42,218 - $53,249
634 Added 16.58%
4,458 $374 Million
Q2 2024

Aug 14, 2024

BUY
$63.15 - $72.88 $241,485 - $278,693
3,824 New
3,824 $262 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Harmony Asset Management LLC Portfolio

Follow Harmony Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harmony Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harmony Asset Management LLC with notifications on news.